Moxie Dwight
SEC insider (Form 3/4/5 filer). CIK 0001803375. CLO & GC at Revance Therapeutics, Inc. (RVNC). 5 reported Form 4/5 transactions since Sep 2024; latest on Feb 6, 2025. Located in NASHVILLE, TN.
Companies Moxie Dwight has filed insider reports for
- Revance Therapeutics, Inc. (RVNC): Officer, CLO & GC
Moxie Dwight
CIK: 0001803375
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (40.0%)
Compensation grants
Other (G, F, J, C, D, …)3 (60.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RVNC
Revance Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Feb 6, 2025RVNC
Revance Therapeutics, Inc.
DispositionDirect96K shares- - Feb 6, 2025RVNC
Revance Therapeutics, Inc.
AwardDirect18.1K shares- - Feb 6, 2025RVNC
Revance Therapeutics, Inc.
DispositionDirect18.1K shares- - Feb 4, 2025RVNC
Revance Therapeutics, Inc.
Tender OfferDirect47.8K shares at avg. $3.65$175K - Feb 3, 2025RVNC
Revance Therapeutics, Inc.
AwardDirect6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 6, 2025 | RVNC Revance Therapeutics, Inc. | Disposition | 95,979 | - | - | Direct |
| Feb 6, 2025 | RVNC Revance Therapeutics, Inc. | Award | 18,125 | - | - | Direct |
| Feb 6, 2025 | RVNC Revance Therapeutics, Inc. | Disposition | 18,125 | - | - | Direct |
| Feb 4, 2025 | RVNC Revance Therapeutics, Inc. | Tender Offer | 47,815 | $3.65 | $174,525 | Direct |
| Feb 3, 2025 | RVNC Revance Therapeutics, Inc. | Award | 5,979 | - | - | Direct |
1-5 of 5 transactions